Blockade of IL-17RA with brodalumab, a human anti-IL-17RA monoclonal antibody, in subjects with inadequately controlled moderate-to-severe asthma taking regular inhaled corticosteroids did not have a significant impact on asthma. Here, IL17RA is linked to asthma.